cellular distribution of TPST-1 and -2 transcripts. To date, no mammalian cell type or cell line has been described that does not express both transcripts. It is important to note that the distribution and relative abundance of the two TPST isoenzymes at the protein level in tissues or cells has not been examined due to the lack of isoenzyme specific antibodies and substrates. Nevertheless, taken together, these data indicate that TPST-1 and -2 are broadly co-expressed in mammalian cells.
Searches of the EST database reveals cDNAs encoding TPST-1 and/or TPST-2 orthologs in many other vertebrate (rat, dog, cow, pig, chicken, zebrafish, fugu, channel catfish, and African clawed frog) and invertebrate species (Caenorhabditis elegans, Drosophila melanogaster, Anopheles gambiae, Ciona intestinalis, Halocynthia roretzi, and Schistosoma japonicum) 2 . It is interesting to note that D. melanogaster has only a single TPST gene, unlike most other species, including C. elegans, which have two TPST genes. Tyrosine sulfated proteins (20) and TPST activity (21) have been described in several plant species, but no plant TPST orthologs have yet been identified and none is apparent in the completed Arabidopsis thaliana genome. Furthermore, no tyrosine sulfated proteins, TPST activity, or putative TPST orthologs have been described in prokaryotes or in yeast.
5 all tyrosine sulfated proteins described to date. Secretory and transmembrane proteins of many different types and classes are represented with secreted proteins comprising the majority. This is consistent with pulse/chase and long-term dual metabolic-labeling studies of various cell lines that demonstrate that most protein bound tyrosine sulfate is in secreted proteins (18) . Based on these dual labeling experiments, it was estimated that, on average, 1 in 20 of the proteins secreted by
HepG2 cells and 1 in 3 of those secreted by fibroblasts contain at least one tyrosine sulfate residue (18) . These studies also indicate that membrane bound proteins are as likely to be sulfated as secreted proteins. The relatively low amount of total protein bound tyrosine sulfate in membrane proteins likely reflects their low abundance relative to secretory proteins.
The location of sulfation has been unambiguously defined in several proteins. Based on the amino acid sequences flanking known tyrosine O-sulfation sites, coupled with in vitro studies on the sulfation of various synthetic peptides, it is evident that there is no sequon for tyrosine O-sulfation per se. Although consensus features for tyrosine O-sulfation have been described, some proteins known to be tyrosine sulfated do not fulfill these features (16) . Nevertheless, it is clear that the dominant characteristic of known sulfation sites is that there are generally between 3 and 4 acidic amino acids within ± 5 residues of the sulfotyrosine.
The SwissProt Group at the Swiss Institute of Bioinformatics has developed a software tool, called Sulfinator 3 , that predicts tyrosine O-sulfation sites in proteins (22) . Although the positive predictive value of this algorithm is uncertain, it can be used to estimate the number of tyrosine sulfated proteins in a genomic-scale dataset. Twenty-six percent of the 5421 mouse proteins in the SwissProt database were predicted to have one or more tyrosine O-sulfation sites by the Sulfinator program. Database entries were examined and those proteins that lacked a predicted signal peptide, signal-anchor, and/or transmembrane domain were excluded, as were proteins in which the predicted sulfation site(s) are cytosolic in orientation, leaving 380 positive predictions which constitute 7% out of original 5,421 proteins (K.L. Moore, unpublished observation). This suggests that as many as 2,100 mouse proteins might be tyrosine sulfated, assuming that the mouse genome encodes 30,000 proteins. Thus, it is very likely that we are only beginning to appreciate the complexity of the substrate repertoire of these enzymes.
A great deal of interest in the field has recently focused on the role of tyrosine O-sulfation in G-protein-coupled receptor (GPCR) function after CCR5, a major HIV co-receptor, was shown to be tyrosine sulfated (23) . Site-directed mutagenesis and chlorate inhibition studies showed that sulfation of one or more tyrosine residues in the N-terminal extracellular domain of CCR5 are required for optimal binding of MIP-1a/CCL3, MIP-1b/CCL4, and RANTES/CCL5, and for optimal HIV co-receptor function. CCR5 mutants in which all four tyrosine residues in the Nterminal extracellular domain were changed to phenylalanine have !100-fold weaker affinity for MIP-1a/CCL3 and RANTES/CCL5. Other studies have shown that synthetic sulfotyrosinecontaining peptides modeled on the N-terminal extracellular domain of CCR5, but not comparable phosphotyrosine-containing peptides, bound to the gp120/CD4 complex and inhibited HIV entry into cells (24) . Likewise, mutagenesis studies indicate that sulfation of tyrosine residue(s) in the Nterminal extracellular domains of CXCR4, CCR2B, CX3CR1, C5a receptor, and the TSH receptor is an important requirement for optimal binding of SDF-1a /CXCL12, MCP-1/CCL2, fractalkine/CX3CL1, C5a, and TSH, respectively (25) (26) (27) (28) (29) . These studies also suggest that TPST-1 and -2 are not processive enzymes.
Regulation of Tyrosine O-sulfation
Evidence that the TPST-1 or TPST-2 genes are subject to transcriptional regulation is very It is possible that tyrosine O-sulfation might be modulated by the action of sulfatases.
However, several lines of evidence argue that efficient mechanisms to desulfate tyrosine sulfate in intact proteins or tyrosine sulfate itself do not exist inside the cell or in the extracellular milieu. Several tyrosine sulfated peptides and proteins have been purified from native sources and the location and stoichiometry of sulfation determined. However, in most cases these proteins/peptides were isolated either using bioassays to follow their purification and/or affinity chromatographic methods that depended on the presence of the sulfate esters, thus precluding an unbiased assessment of stoichiometry in vivo. Two exceptions are notable because they were clearly purified from an extracellular source, unlike most of the others, which were purified from tissues, and they were isolated using methods that were independent of the sulfation state of the protein. The activation peptide of human plasma-derived factor IX is stoichiometrically sulfated at Tyr 155 (37) .
Human glycoprotein Iba purified from human platelets has three tyrosine O-sulfation sites. 
Role of Tyrosine O-sulfation in Protein Function
To date, 62 tyrosine-sulfated proteins have been identified (Table I , Supplemental Data). For the majority of these, a role for sulfation in the function(s) of the proteins has not been described. factor VIII is required for optimal binding to von Willebrand factor, which acts as a carrier protein for factor VIII in plasma, thereby increasing the circulating half-life of factor VIII in vivo (47) .
Thus, this mutation may directly explain the mild to moderate hemophilia in these patients.
Emerging Insights from Tpst1 and Tpst2 Knockout Mice
We have begun to assess the role of tyrosine O-sulfation in vivo using mice in which the 2 Sulfakinins are a family of neuropeptides that have been purified from several species of insects and crustacea. They vary in length from 9 to 19 amino acids and have a conserved carboxy-terminal heptapeptide sequence DY(SO 3 )GHMRF-NH 2 . Preprosulfakinin cDNAs have been identified in three insect species, including Drosophila melanogaster, Calliphora vomitoria, and Lucilla cuprina (46, 77) . They each encode precursor proteins that are proteolytic processed, carboxy-terminal a-amidated, and tyrosine sulfated, yielding two sulfakinin peptides SK-I and SK-II.
Abbreviations used: PSGL-1, P-selectin glycoprotein ligand-1; MAFp3, Microciona aggregation factor core protein, isoform 3; MAGP-1, myelin-associated glycoprotein-1; POMC, proopiomelanocortin; PAM, peptidylglycine a-amidating monooxygenase; SGNE1, secretory granule neuroendocrine protein 1; TSH, thyroid stimulating hormone.
